Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute lymphocytic leukemia
|
222 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Adult Myelodysplastic Syndrome
|
20 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Aleukemic mast cell leukemia
|
2 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
anaphylaxis
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Benign Mastocytoma
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Bone marrow infiltration
|
3 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Carcinogenesis
|
355 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
Childhood Myelodysplastic Syndrome
|
20 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Diarrhea
|
63 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Fatigue
|
67 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Hematologic Neoplasms
|
60 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Hereditary Leiomyomatosis and Renal Cell Cancer
|
59 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Hypereosinophilia
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Idiopathic anaphylaxis
|
2 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Leukemia, Myelomonocytic, Chronic
|
28 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Mantle cell lymphoma
|
19 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Mast Cell Neoplasm
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Mast-Cell Sarcoma
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Mastocytoma
|
4 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Medium-chain acyl-coenzyme A dehydrogenase deficiency
|
114 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Microphthalmos
|
40 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Monoclonal mast cell activation syndrome
|
2 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Myeloid Leukemia, Chronic
|
115 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1 | 2014 | 2014 | |||||||
Myeloproliferative disease
|
43 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Myeloproliferative Neoplasm, Unclassifiable
|
3 | 0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 |